These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23487237)

  • 1. Repeated adverse hematologic reactions associated with valproic acid use in a patient with acquired renal insufficiency.
    Kuo SC; Yeh YW; Chen CY; Yeh CB; Tzeng NS; Mao WC
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E57-8. PubMed ID: 23487237
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual cause of gross hematuria: questions and answers.
    Taktak A; Acar B; Gür G; Tiryaki T; Albayrak A; Çakar N
    Pediatr Nephrol; 2015 May; 30(5):767, 769-70. PubMed ID: 24357455
    [No Abstract]   [Full Text] [Related]  

  • 3. A case with hyperammonemic encephalopathy triggered by single dose valproate.
    Ciftci S; Guler A; Deveci E; Celebisoy N; Yuceyar N
    Neurol Sci; 2016 Dec; 37(12):2017-2018. PubMed ID: 27436290
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of acetyl-l-carnitine in elderly patient who presented with hyperammonemia associated with administration of sodium valproate.
    Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Dec; 30():179. PubMed ID: 29096385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valproic acid derivatives: toxicity and adverse effects].
    Kłosiewicz L; Puzyński S
    Psychiatr Pol; 1987; 21(1):57-61. PubMed ID: 3112824
    [No Abstract]   [Full Text] [Related]  

  • 6. Stupor and fast activity on electroencephalography in a child treated with valproate.
    Mastrangelo M; Mariani R; Spalice A; Rocchi V; Iannetti P
    Pediatr Neurol; 2009 Jul; 41(1):53-6. PubMed ID: 19520277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual field defect during therapy with valproic-acid.
    Tilz C; Wang-Tilz Y; Jünemann A; Stefan H; Michelson G
    Eur J Neurol; 2007 Aug; 14(8):929-32. PubMed ID: 17662017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sodium valproate-induced kinky hair].
    Caneppele S; Mazereeuw-Hautier J; Bonafé JL
    Ann Dermatol Venereol; 2001 Feb; 128(2):134-5. PubMed ID: 11275589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurostabilizers for migraine prevention. From dosage administration to patient expectations.
    Wright W
    Adv Nurse Pract; 2007 Feb; 15(2):52-4, 56-8, 85. PubMed ID: 19998927
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effects of valproate.
    Schmidt D
    Epilepsia; 1984; 25 Suppl 1():S44-9. PubMed ID: 6425046
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate prescribing trends for non-epilepsy indications in women of reproductive age warrants effective measures and increased surveillance.
    Kaplan YC; Abdelkader N
    Seizure; 2016 Aug; 40():13-4. PubMed ID: 27289305
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clumsiness, confusion, coma, and valproate.
    Ellaway CJ; Bennetts B; Tuck RR; Wilcken B
    Lancet; 1999 Apr; 353(9162):1408. PubMed ID: 10227223
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.
    Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD
    Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.
    Kochar DK; Garg P; Bumb RA; Kochar SK; Mehta RD; Beniwal R; Rawat N
    QJM; 2005 Jan; 98(1):29-34. PubMed ID: 15625351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
    Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
    Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced delirium in a demented patient.
    Gareri P; Lacava R; Cotroneo A; Bambara V; Marigliano N; Castagna A; Costantino DS; Ruotolo G; de Sarro G
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():113-8. PubMed ID: 19836623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatal bone marrow involvement in voluntary acute poisoning with sodium dipropylacetate].
    Boillot A; Bourgeois F; Barale F; Lenys R; Daoudal P; Delacour JL
    Nouv Presse Med; 1981 May; 10(24):2038. PubMed ID: 6789301
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive oxidative haemolysis and renal failure caused by high dose vitamin C.
    Rees MJ; Strach MC; Burbury K; Phillips KA
    Med J Aust; 2018 Sep; 209(6):248-249. PubMed ID: 30208815
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.